Share Email Print
cover

Proceedings Paper

Molecular application of spectral photoacoustic imaging in pancreatic cancer pathology
Author(s): Minalini Lakshman; Clinton Hupple; Ines Lohse; David Hedley; Andrew Needles; Catherine Theodoropoulos
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Spectral imaging is an advanced photo-acoustic (PA) mode that can discern optical absorption of contrast agent(s) in the tissue micro-environment. This advancement is made possible by precise control of optical wavelength using a tunable pulsed laser, ranging from 680-970 nm. Differential optical absorption of blood oxygenation states makes spectral imaging of hemoglobin ideal to investigate remodeling of the tumor microenvironment- a molecular change that renders resistance to standard cancer treatment. Approach: Photo-acoustic imaging was performed on the Vevo® LAZR system (VisualSonics) at 5-20 Hz. Deep abdominal imaging was accomplished with a LZ250D probe at a center frequency of 21MHz and an axial resolution of 75 μm. The tumor model was generated in an immune compromised mouse by surgical implantation of primary patient derived tumors, in the pancreas. Results: Spectral imaging for oxygen saturation at 750 nm and 850 nm characterized this tumor with a poorly oxygenated core surrounded by a well oxygenated periphery. Multispectral imaging identified a sub region in the core with a four-fold signal exclusively at 750 and 800 nm. A co-registered 2D image of this region was shown to be echogenic and calcification was suspected. Perfusion imaging with contrast enhanced ultrasound using microbubbles (Vevo MicroMarker® contrast agents, VisualSonics) identified functional vessels towards this sub region. Histology confirmed calcification and vascularization in the tumor core. Taken together, non-invasive characterization of the tumor microenvironment using photo-acoustics rendered spectral imaging a sensitive tool to monitor molecular changes representative of progression of pancreatic cancer that kills within 6 months of diagnosis.

Paper Details

Date Published: 11 December 2012
PDF: 7 pages
Proc. SPIE 8553, Optics in Health Care and Biomedical Optics V, 855319 (11 December 2012); doi: 10.1117/12.999958
Show Author Affiliations
Minalini Lakshman, VisualSonics Inc. (Canada)
Clinton Hupple, VisualSonics Inc. (Canada)
Ines Lohse, Ontario Cancer Institute (Canada)
Campbell Family Cancer Research Institute (Canada)
David Hedley, Ontario Cancer Institute (Canada)
Campbell Family Cancer Research Institute (Canada)
Univ. of Toronto (Canada)
Andrew Needles, VisualSonics Inc. (Canada)
Catherine Theodoropoulos, VisualSonics Inc. (Canada)


Published in SPIE Proceedings Vol. 8553:
Optics in Health Care and Biomedical Optics V
Qingming Luo; Ying Gu; Xingde D. Li, Editor(s)

© SPIE. Terms of Use
Back to Top